🇺🇸 FDA
Patent

US 8372848

Melanin-concentrating hormone receptor antagonists and methods of use

granted A61KA61K31/4015A61P

Quick answer

US patent 8372848 (Melanin-concentrating hormone receptor antagonists and methods of use) held by The Regents of the University of California expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4015, A61P, A61P13/02, A61P25/24